Histamine in growth, development and cancer: Further evidence that histamine H1-antagonists cause joint weakness in rat foetuses

Inflammation Research

Volumn 51, Issue SUPPL.1, 2002, Pages

  Sturman, G ^a   Freeman, P ^a   Meade, H M ^a   Seeley, N A ^a  

^a UNIVERSITY OF EAST LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIVASTINE; ANTAZOLINE; CHLORPHENIRAMINE; CINNARIZINE; HISTAMINE H1 RECEPTOR ANTAGONIST; MEPYRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BONE DEVELOPMENT; CONFERENCE PAPER; FETUS; FETUS DEVELOPMENT; FETUS MALFORMATION; IMMUNOHISTOCHEMISTRY; NONHUMAN; ORGANOGENESIS; OSSIFICATION; RAT; ANIMAL; ARTHROPATHY; ARTICLE; BONE; CHEMICALLY INDUCED DISORDER; CLEFT PALATE; CONGENITAL MALFORMATION; FEMALE; JOINT; PATHOLOGY; PREGNANCY; PRENATAL DEVELOPMENT;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; BONE AND BONES; CLEFT PALATE; FEMALE; HISTAMINE H1 ANTAGONISTS; JOINT DISEASES; JOINTS; PREGNANCY; RATS;

EID: 0036221224     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. The formation of histamine in the rat fetus
2. Histamine metabolism in the pregnant mouse
3. 1 antagonists
4. 2-antagonists on pre- and post-natal development in the rat
5. Double staining technique for rat fetus skeletons in teratogen studies
6. Cleft palate and maternal diphenhydramine intake
7. Teratogenic effects of buclizine and hydroxyzine in the rat and chlorcyclizine in the mouse
8. Distribution of histamine in developing rat tissues